The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Magnesium sulphate for preventing preterm birth in threatened preterm labour
Open accessAbstract
BACKGROUND: Magnesium sulphate has been used in some settings as a tocolytic agent to inhibit uterine activity in women in preterm labour with the aim of preventing preterm birth. OBJECTIVES: To assess the effects of magnesium sulphate therapy given to women in threatened preterm labour with the aim of preventing preterm birth and its sequelae. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (last searched 31 January 2014). SELECTION CRITERIA: Randomised controlled trials of magnesium sulphate as the only tocolytic, administered by any route, compared with either placebo, no treatment or alternative tocolytic therapy (not magnesium sulphate) to women considered to be in preterm labour. DATA COLLECTION AND ANALYSIS: At least two review authors assessed trial eligibility and risk of bias and undertook data extraction independently. MAIN RESULTS: The 37 included trials (total of 3571 women and over 3600 babies) were generally of moderate to high risk of bias. Antenatal magnesium sulphate was compared with either placebo, no treatment, or a range of alternative tocolytic agents.For the primary outcome of giving birth within 48 hours after trial entry, no significant differences were seen between women who received magnesium sulphate and women who did not (whether placebo/no alternative tocolytic drug, betamimetics, calcium channel blockers, cox inhibitors, prostaglandin inhibitors, or human chorionic gonadotropin) (19 trials, 1913 women). Similarly for the primary outcome of serious infant outcome, there were no significant differences between the infants exposed to magnesium sulphate and those not (whether placebo/no alternative tocolytic drug, betamimetics, calcium channel blockers, cox inhibitors, prostaglandin inhibitors, human chorionic gonadotropin or various tocolytic drugs) (18 trials; 2187 babies). No trials reported the outcome of extremely preterm birth. In the seven trials that reported serious maternal outcomes, no events were recorded.In the group treated with magnesium sulphate compared with women receiving antenatal placebo or no alternative tocolytic drug, a borderline increased risk of total death (fetal, neonatal, infant) was seen (risk ratio (RR) 4.56, 95% confidence interval (CI) 1.00 to 20.86; two trials, 257 babies); none of the comparisons between magnesium sulphate and other classes of tocolytic drugs showed differences for this outcome (10 trials, 991 babies). The outcomes of neonatal and/or infant deaths and of fetal deaths did not show differences between magnesium sulphate and no magnesium sulphate, whether compared with placebo/no alternative tocolytic drug, or any specific class of tocolytic drug. For most of the other secondary outcomes, there were no significant differences between magnesium sulphate and the control groups for risk of preterm birth (except for a significantly lower risk with magnesium sulphate when compared with barbiturates in one trial of 65 women), gestational age at birth, interval between trial entry and birth, other neonatal morbidities, or neurodevelopmental outcomes. Duration of neonatal intensive care unit stay was significantly increased in the magnesium sulphate group compared with the calcium channel blocker group, but not when compared with cox inhibitors or prostaglandin inhibitors. No maternal deaths were reported in the four trials reporting this outcome. Significant differences between magnesium sulphate and controls were not seen for maternal adverse events severe enough to stop treatment, except for a significant benefit of magnesium sulphate compared with betamimetics in a single trial. AUTHORS' CONCLUSIONS: Magnesium sulphate is ineffective at delaying birth or preventing preterm birth, has no apparent advantages for a range of neonatal and maternal outcomes as a tocolytic agent and its use for this indication may be associated with an increased risk of total fetal, neonatal or infant mortality (in contrast to its use in appropriate groups of women for maternal, fetal, neonatal and infant neuroprotection where beneficial effects have been demonstrated).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 6,935
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Roberts, D., Brown, J., Medley, N., & Dalziel, S. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub3 · Cited by 2,806
Self-citationBorn too soon : the Global action report on preterm birth
Howson, C. P., Kinney, M., & Lawn, J. E. (2012) · Cited by 1,928
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Roberts, D., & Dalziel, S. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub2 · Cited by 1,578
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
Doyle, L. W., Crowther, C. A., Middleton, P., Marret, S., & Rouse, D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004661.pub3 · Cited by 807
Self-citationMagnesium sulphate and other anticonvulsants for women with pre-eclampsia
Duley, L., Gülmezoglu, A. M., Henderson-Smart, D. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000025.pub2 · Cited by 586
Tocolytic therapy for preterm delivery: systematic review and network meta-analysis
Haas, D. M., Caldwell, D. M., Kirkpatrick, P., McIntosh, J. J., & Welton, N. J. (2012) · BMJ · doi:10.1136/bmj.e6226 · Cited by 419
Boyle, E. M., Poulsen, G., Field, D. J., Kurinczuk, J. J., Wolke, D., Alfirevic, Z., & Quigley, M. A. (2012) · BMJ · doi:10.1136/bmj.e896 · Cited by 412
Practice Bulletin No. 127: Management of Preterm Labor
(2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31825af2f0 · Cited by 269
Mittendorf, R., Dambrosia, J., Pryde, P. G., Lee, K.-S., Gianopoulos, J. G., Besinger, R. E., & Tomich, P. G. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.123544 · Cited by 265
Magnesium protects against neurological deficit after brain injury
McIntosh, T. K., Vink, R., Yamakami, I., & Faden, A. I. (1989) · Brain Research · doi:10.1016/0006-8993(89)91188-8 · Cited by 231
Is tocolytic magnesium sulphate associated with increased total paediatric mortality?
Mittendorf, R., Covert, R., Boinan, J., Khoshnood, B., Lee, K.-S., & Siegler, M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)24047-x · Cited by 219
Magnesium sulphate for preventing preterm birth in threatened preterm labour
Crowther, C. A., Hiller, J. E., & Doyle, L. W. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001060 · Cited by 195
Self-citationTocolytic Therapy: A Meta-Analysis and Decision Analysis
Haas, D. M., Imperiale, T. F., Kirkpatrick, P. R., Klein, R. W., Zollinger, T. W., & Golichowski, A. M. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318199924a · Cited by 183
Randomized investigation of magnesium sulfate for prevention of preterm birth
Cox, S. M., Sherman, M. L., & Leveno, K. J. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)91065-k · Cited by 146
Functional abilities at age 4 years of children born before 29 weeks of gestation.
Johnson, A., Townshend, P., Yudkin, P. L., Bull, D., & Wilkinson, A. R. (1993) · BMJ · doi:10.1136/bmj.306.6894.1715 · Cited by 143
Glock, J. L., & Morales, W. J. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90035-h · Cited by 132
Magnesium Sulfate Tocolysis: Time to Quit
Grimes, D. A., & Nanda, K. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000236445.18265.93 · Cited by 111
Effective Care in Pregnancy and Childbirth: A Synopsis
Enkin, M. W., Keirse, M. J. N. C., Renfrew, M. J., & Neilson, J. P. (1995) · Birth · doi:10.1111/j.1523-536x.1995.tb00567.x · Cited by 110
Morales, W. J., & Madhav, H. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90138-9 · Cited by 108
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour
Han, S., Crowther, C. A., & Moore, V. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000940.pub3 · Cited by 100
Self-citationMagnesium Sulfate Compared With Nifedipine for Acute Tocolysis of Preterm Labor
Lyell, D. J., Pullen, K. M., Campbell, L., Ching, S., Druzin, M. L., Chitkara, U., Burrs, D., Caughey, A. B., & El-Sayed, Y. Y. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000269048.06634.35 · Cited by 77
Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor
Larmon, J. E., Ross, B. S., May, W. L., Dickerson, G. A., Fischer, R. G., & Morrison, J. C. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70388-1 · Cited by 69
Adverse and beneficial effects of tocolytic therapy
Pryde, P. G., Besinger, R. E., Gianopoulos, J. G., & Mittendorf, R. L. (2001) · Seminars in Perinatology · doi:10.1053/sper.2001.27547 · Cited by 56
Terrone, D. A., Rinehart, B. K., Kimmel, E. S., May, W. L., Larmon, J. E., & Morrison, J. C. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107334 · Cited by 44
Role of magnesium and other divalent cations in ATP-utilizing enzymes.
Mildvan, A. S. (1987) · PubMed · Cited by 38
Rofecoxib Versus Magnesium Sulfate to Arrest Preterm Labor: A Randomized Trial
McWhorter, J., Carlan, S. J., O'Leary, T., Richichi, K., & O’Brien, W. F. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000124784.48287.15 · Cited by 37
Changes in Survival and Neonatal Morbidity in Infants with a Birth Weight of 750 g or Less
Claas, M. J., Bruinse, H. W., van der Heide-Jalving, M., Termote, J. U. M., & de Vries, L. S. (2010) · Neonatology · doi:10.1159/000285715 · Cited by 32
Effect of antenatal tocolysis on neonatal outcomes
Klauser, C. K., Briery, C. M., Keiser, S., Martin, R. W., Kosek, M. A., & Morrison, J. C. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.714819 · Cited by 28
Celecoxib versus magnesium sulfate to arrest preterm labor: Randomized trial
Borna, S., & Saeidi, F. M. (2007) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2007.00623.x · Cited by 27
Lack of effect of antenatal indomethacin on fetal cerebral blood flow
Parilla, B. V., Tamura, R. K., Cohen, L. S., & Clark, E. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70330-2 · Cited by 26
Poor Outcomes at Discharge Among Extremely Premature Infants
Kugelman, A., Bader, D., Lerner‐Geva, L., Boyko, V., Levitzki, O., Riskin, A., & Reichman, B. L. (2012) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2011.891 · Cited by 24
How, H. Y., Zafaranchi, L., Stella, C. L., Recht, K., Maxwell, R. A., Sibai, B. M., & Spinnato, J. A. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.02.030 · Cited by 23
A Comparative Study of Ketorolac (Toradol) and Magnesium Sulfate for Arrest of Preterm Labor
Schorr, S. J., Ascarelli, M. H., Rust, O. A., ROSE, E. L., Calfee, E. F., Perry, K. G., & Morrison, J. C. (1998) · Southern Medical Journal · doi:10.1097/00007611-199811000-00007 · Cited by 20
Hayek, L. C. (1994) · Smithsonian Digital Repository (Smithsonian Institution) · Cited by 16
[Magnesium sulfate in prevention of preterm labor].
Ma, L. (1992) · PubMed · Cited by 11
Cited by
A systematic review of interventions for children with cerebral palsy: state of the evidence
Novak, I., Mcintyre, S., Morgan, C., Campbell, L., Dark, L., Morton, N., Stumbles, E., Wilson, S., & Goldsmith, S. (2013) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12246 · Cited by 1,298
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
Doyle, L. W., Crowther, C. A., Middleton, P., Marret, S., & Rouse, D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004661.pub3 · Cited by 807
Self-citationMagnesium sulphate and other anticonvulsants for women with pre-eclampsia
Duley, L., Gülmezoglu, A. M., Henderson-Smart, D. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000025.pub2 · Cited by 586
Iams, J. D., Romero, R., Culhane, J. F., & Goldenberg, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60108-7 · Cited by 500
Tocolytic therapy for preterm delivery: systematic review and network meta-analysis
Haas, D. M., Caldwell, D. M., Kirkpatrick, P., McIntosh, J. J., & Welton, N. J. (2012) · BMJ · doi:10.1136/bmj.e6226 · Cited by 419
Metadata
- Authors
- Crowther, C. A., Brown, J., McKinlay, C. J., & Middleton, P.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-08-15
- Volume
- 2014
- Issue
- 8
- Pages
- CD001060-CD001060
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1539453637
- Cited by
- 317
- References
- 38
- FWCI
- 16.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.